Detalles de la búsqueda
1.
Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial.
Lancet Oncol;
18(5): 599-610, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373005
2.
Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial.
Lancet Oncol;
18(5): 587-598, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28373007
3.
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.
Lancet Oncol;
17(10): 1374-1385, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27592805
4.
T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment.
Cancer Immunol Immunother;
62(2): 245-56, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22878899
5.
An optimized IL-12-Fc expands its therapeutic window, achieving strong activity against mouse tumors at tolerable drug doses.
Med;
4(5): 326-340.e5, 2023 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37059099
6.
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody.
PLoS One;
13(4): e0191926, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29617360
7.
Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab).
AIDS;
30(16): 2487-2493, 2016 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27490642
8.
Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.
J Clin Oncol;
30(17): 2046-54, 2012 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22547592
Resultados
1 -
8
de 8
1
Próxima >
>>